EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$29.06
-0.99 (-3.29%)
Performance
1D
—
1W
—
1M
—
3M
+10.28%
6M
+81.06%
1Y
+27.46%
YTD
+22.36%
Open$30.10
Previous Close$30.05
Day High$30.44
Day Low$28.87
52W High$31.82
52W Low$10.60
Volume—
Avg Volume1.03M
Market Cap3.21B
P/E Ratio—
EPS$-1.58
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$26.49
Above
SMA 200
$18.41
Above
RSI (14)
53.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+142.4% upside
Current
$29.06
$29.06
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |